Posts from ‘May, 2009’

Agreement to create world class cancer management centre of excellence harnessing state-of-the-art Elekta technologies OTTAWA, May 27 (HSMN NewsFeed) — Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support pro…
Devices, Oncology
Elekta, Elekta Synergy, IGRT, IMRT, radiotherapy

Industry Leaders Bring Deep Oncology and Company Building Experience CAMBRIDGE, Mass.–(HSMN NewsFeed)–Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer …
Biopharmaceuticals, Oncology, Personnel
Agios Pharmaceuticals

Funding supports the continued U.S. roll-out of the Z-View® Aberrometer and wavefront guided iZon® High Resolution Lenses VISTA, Calif., May 26 (HSMN NewsFeed) — Ophthonix, a company that has developed advanced vision-correction products that…
Devices, Ophthalmology, Venture Capital
Ophthonix, iZon Lens, Z-View Aberrometer

Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) today welcomed publication of results from the …
Devices, Interventional, Neurology
Boston Scientific, coil embolization, GDC Coils, aneurysm, ISAT data

Two-Year Follow-Up Data Includes Eighty Percent Progression-Free Survival Rate in Gleevec-Resistant or Intolerant Patients with Chronic Phase CML NEW YORK–(HSMN NewsFeed)–Bristol-Myers Squibb Company (NYSE: BMY ) today announced that the U.S. Food and Dru…
Biopharmaceuticals, Oncology
Bristol-Myers Squibb, SPRYCEL, dasatinib, chronic myeloid leukemia

Conference call to be Held at 9:00 a.m. Eastern Time Today, May 26, 2009 SILVER SPRING, Md., May 26 (HSMN NewsFeed) — United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approv…
Biopharmaceuticals, FDA
United Therapeutics, ADCIRCA, tadalafil, pulmonary arterial hypertension

CHICAGO, May 26 (HSMN NewsFeed) — ProCure Treatment Centers, Inc., (ProCure) has selected Elekta to provide workflow enhancing software and treatment planning systems for its second IBA-equipped proton therapy center, which is under construction in subu…
Devices, Oncology
Elekta, ProCure Treatment Centers, proton therapy, radiotherapy, MOSAIQ

Both Rapid and Sustained Pain Relief for up to 48 Hours Conference call to be Held Today at 8:30 a.m. ET MOUNTAIN VIEW, Calif., May 26 (HSMN NewsFeed) — MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced today that the efficacy portion of its fir…
Biopharmaceuticals
MAP Pharmaceuticals, LEVADEX, MAP0004, migraine

LOS ANGELES–(HSMN NewsFeed)–Abraxis BioScience, Inc. (NASDAQ: ABII ), a fully integrated biotechnology company, today announced that Marty J. Duvall has joined the management team as Senior Vice President, Global Product management and International Commercial Op…
Biopharmaceuticals, Personnel
Abraxis BioScience

Reno, Nevada, May 22, 2009 - (HSMN NewsFeed) - SutureAssist(TM) solves the problem of dislodging the press-fit needle from the lightweight tray without disturbing its job on the Mayo stand thereby promoting safety and improving patient outcome. Saf…
Devices, Surgery
Equinox Surgical Solutions, SutureAssist